| Target Price | $252.64 |
| Price | $192.19 |
| Potential | 31.45% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target Honeywell International 2026 . The average Honeywell International target price is $252.64. This is 31.45% higher than the current stock price. The highest price target is $315.00 63.90% , the lowest is $216.35 12.57% . | |
| A rating was issued by 32 analysts: 21 Analysts recommend Honeywell International to buy, 11 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Honeywell International stock has an average upside potential 2026 of 31.45% . Most analysts recommend the Honeywell International stock at Purchase. |
26 Analysts have issued a sales forecast Honeywell International 2025 . The average Honeywell International sales estimate is $41.2b . This is 1.31% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $42.9b 5.57% , the lowest is $39.9b 1.86% .
This results in the following potential growth metrics:
| 2024 | $38.5b | 5.01% |
|---|---|---|
| 2025 | $41.2b | 7.02% |
| 2026 | $40.3b | 2.12% |
| 2027 | $42.5b | 5.46% |
| 2028 | $45.2b | 6.27% |
20 Analysts have issued an Honeywell International EBITDA forecast 2025. The average Honeywell International EBITDA estimate is $10.7b . This is 11.38% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $11.9b 23.71% , the lowest is $9.8b 2.01% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $9.4b | 8.24% |
|---|---|---|
| 2025 | $10.7b | 14.16% |
| 2026 | $11.3b | 5.68% |
| 2027 | $12.3b | 8.30% |
| 2028 | $12.2b | 0.94% |
| 2024 | 24.44% | 3.08% |
|---|---|---|
| 2025 | 26.06% | 6.65% |
| 2026 | 28.14% | 7.98% |
| 2027 | 28.90% | 2.70% |
| 2028 | 26.94% | 6.78% |
27 Honeywell International Analysts have issued a net profit forecast 2025. The average Honeywell International net profit estimate is $6.8b . This is 11.53% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $7.2b 17.09% , the lowest is $6.6b 7.61% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $5.7b | 0.83% |
|---|---|---|
| 2025 | $6.8b | 19.82% |
| 2026 | $6.8b | 0.10% |
| 2027 | $7.5b | 8.89% |
| 2028 | $8.2b | 10.60% |
| 2024 | 14.82% | 3.98% |
|---|---|---|
| 2025 | 16.59% | 11.95% |
| 2026 | 16.97% | 2.29% |
| 2027 | 17.52% | 3.24% |
| 2028 | 18.23% | 4.05% |
27 Analysts have issued a Honeywell International forecast for earnings per share. The average Honeywell International EPS is $10.77 . This is 12.30% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.30 17.83% , the lowest is $10.39 8.34% .
This results in the following potential growth metrics and future valuations:
| 2024 | $8.71 | 2.83% |
|---|---|---|
| 2025 | $10.77 | 23.65% |
| 2026 | $10.78 | 0.09% |
| 2027 | $11.74 | 8.91% |
| 2028 | $12.98 | 10.56% |
| Current | 20.04 | 24.07% |
|---|---|---|
| 2025 | 17.85 | 10.93% |
| 2026 | 17.83 | 0.11% |
| 2027 | 16.38 | 8.13% |
| 2028 | 14.81 | 9.58% |
Based on analysts' sales estimates for 2025, the Honeywell International stock is valued at an EV/Sales of 3.54 and an P/S ratio of 2.96 .
This results in the following potential growth metrics and future valuations:
| Current | 3.58 | 19.73% |
|---|---|---|
| 2025 | 3.54 | 1.22% |
| 2026 | 3.61 | 2.16% |
| 2027 | 3.43 | 5.18% |
| 2028 | 3.22 | 5.90% |
| Current | 3.00 | 23.78% |
|---|---|---|
| 2025 | 2.96 | 1.29% |
| 2026 | 3.03 | 2.16% |
| 2027 | 2.87 | 5.18% |
| 2028 | 2.70 | 5.90% |
Honeywell International...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| B of A Securities |
Buy
➜
Underperform
|
Downgrade | Nov 18 2025 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Nov 10 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 28 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 27 2025 |
| RBC Capital |
Sector Perform
➜
Outperform
|
Upgrade | Oct 27 2025 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 24 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
B of A Securities:
Buy
➜
Underperform
|
Nov 18 2025 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Nov 10 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 28 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Oct 27 2025 |
|
Upgrade
RBC Capital:
Sector Perform
➜
Outperform
|
Oct 27 2025 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 24 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


